[1] The company's founder, John Tagg, has conducted research investigating the amount of bacteria present within a diet and their effects on personal hygiene.

[2] After contracting rheumatic fever at age 12, Tagg later decided, as a young microbiology student, to seek an effective way of countering the disease.

[6] Blis Technologies hold the world-first patent for their strain of the oral bacteria, Streptococcus salivarius, claimed to be beneficial for humans, which won the 2010 Frost & Sullivan award for Global Entrepreneurship.

[8] A secondary product to ThroatGuard, containing BLIS K12 in a powder form suitable for children and infants, was developed and branded ToddlerProtect.

[10] Blis Technologies introduced a new probiotic to the New Zealand market in October 2012, focused on fighting the bacteria associated with tooth decay and periodontal disease.